glp-1 for autoimmune inflammation Association between diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study GLP-1 Genetics: How Genes Affect

These drugs have achieved remarkable weight loss and multiple cardiometabolic benefits, including improvements in glycemic control, lipid profiles, blood pressure, inflammation, and hepatic steatosis

Studies show that stopping GLP-1 therapy can lead to weight regain, which is why we focus on sustainable lifestyle changes alongside medication

As the central organ of cholesterol metabolism, the liver directly affects the bodys cholesterol metabolism homeostasis

Thigh: If you choose the front of your thigh as a Wegovy injection site, select a spot on the front outer part of your upper thigh about halfway between your knee and hip

Another factor to consider is long-term benefits with weight-loss or possible disease improvement would require continued use of GLP-1 agonist in addition to other IBD treatment options, which can be an additional financial or emotional burden on patients that would need further exploring as well.